2024/09/27 08:08:21 | |
---|---|
Price | |
93.70 EUR | |
Difference | 0.32% (0.30) |
ISIN | US4595061015 |
Symbol | IFF |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 23,955 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 94.18 EUR (320) |
Ask (Ask size) | 94.50 EUR (320) |
Open | 93.70 EUR |
High | 93.70 EUR |
Low | 93.70 EUR |
Close (prev. day) | 93.40 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/09/27 08:08:21 | |
---|---|
Price | |
93.70 EUR | |
Difference | 0.32% (0.30) |
ISIN | US4595061015 |
Symbol | IFF |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 23,955 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 94.18 EUR (320) |
Ask (Ask size) | 94.50 EUR (320) |
Open | 93.70 EUR |
High | 93.70 EUR |
Low | 93.70 EUR |
Close (prev. day) | 93.40 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +23.71% | +45.71% | -17.64% |
Perf (abs.) | +17.90 | +29.30 | -20.00 |
Beta | 0.70 | 0.74 | 0.93 |
Volatility | 27.04 | 27.39 | 32.49 |
Ø price 5 days | Ø volume 5 days (pcs.) | 92.49 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 91.89 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 89.89 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 79.23 EUR (0) |
YTD High | date | 93.80 EUR (2024/09/02) |
YTD Low | date | 67.40 EUR (2024/02/29) |
52 Weeks High | date | 93.80 EUR (2024/09/02) |
52 Weeks Low | date | 59.20 EUR (2023/10/09) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/09/27 | 17:32 | 94.58 EUR | 0.00 | 5 |
Tradegate | 2024/09/27 | 17:28 | 94.30 EUR | 0.02 | 4 |
Stuttgart | 2024/09/27 | 08:03 | 93.68 EUR | 0.00 | 1 |
NYSE | 2024/09/27 | 21:07 | 105.325 USD | 64.55 | 12,886 |
Munich | 2024/09/27 | 08:02 | 93.68 EUR | 0.00 | 1 |
London Stock Exchange | 2020/10/13 | 15:46 | 101.419 EUR | 0.00 | 1 |
Frankfurt | 2024/09/27 | 10:16 | 94.24 EUR | 0.00 | 2 |
Duesseldorf | 2024/09/27 | 19:31 | 93.76 EUR | 0.00 | 5 |
Berlin | 2024/09/27 | 08:08 | 93.70 EUR | 0.00 | 1 |
INTERNATIONAL FLAVORS & FRAGRANCES INC. |
- - |
521 West 57th Street - 10019-2960 New York |
Telefon: +1-212-765-5500 |
Fax: +1-212-708-7132 |
E-mail: - |
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the worldšs finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY. |
Roger Ferguson | Chairman of Board of Directors |
Kathryn Boor | Member of Board of Directors |
Carol Davidson | Member of Board of Directors |
Christina Gold | Member of Board of Directors |
Dawn Willoughby | Member of Board of Directors |
Gary Hu | Member of Board of Directors |
John Ferraro | Member of Board of Directors |
Kevin O'Byrne | Member of Board of Directors |
Margarita Paláu-Hernández | Member of Board of Directors |
Mark Costa | Member of Board of Directors |
J. Erik Fyrwald | Chairman of Managing Board |
Angela Strzelecki | Member of Executive Committee |
Glenn Richter | Member of Executive Committee |
Jennifer Johnson | Member of Executive Committee |
Michael DeVeau | Member of Executive Committee |
Simon Herriott | Member of Executive Committee |
Vic Verma | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer